Late-Breaking Abstracts should report recently generated research on important basic, translational, or clinical discoveries in pulmonary, critical care, or sleep medicine.
Deadline: 5 p.m. ET, Wednesday, Jan. 29
The top three submissions chosen by the ATS Drug Device Discovery and Development (DDDD) Committee will pitch their highly innovative research proposals to a panel of translational science experts representing academia, industry, and governmental sectors in front of a live audience at the ATS International Conference.
Deadline: Feb. 10
When you become a member of our global American Thoracic Society community of 16,000+ health care providers and researchers, you'll have access to:
The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.
© 1998 - 2024 American Thoracic Society, all rights reserved.
American Thoracic Society
25 Broadway
New York, NY 10004
United States of America
Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498
Email: conferencequestions@thoracic.org
Privacy Statement | Term of Use | COI
Conference Code of Conduct